258 related articles for article (PubMed ID: 16939629)
1. Prostanoids in the therapy of glaucoma.
Ishida N; Odani-Kawabata N; Shimazaki A; Hara H
Cardiovasc Drug Rev; 2006; 24(1):1-10. PubMed ID: 16939629
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy.
Denis P; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
Curr Med Res Opin; 2007 Mar; 23(3):601-8. PubMed ID: 17355741
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug.
Takagi Y; Nakajima T; Shimazaki A; Kageyama M; Matsugi T; Matsumura Y; Gabelt BT; Kaufman PL; Hara H
Exp Eye Res; 2004 Apr; 78(4):767-76. PubMed ID: 15037111
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic uses of prostaglandin F(2α) analogues in ocular disease and novel synthetic strategies.
Dams I; Wasyluk J; Prost M; Kutner A
Prostaglandins Other Lipid Mediat; 2013; 104-105():109-21. PubMed ID: 23353557
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
Stewart WC; Konstas AG; Nelson LA; Kruft B
Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.
Aptel F; Cucherat M; Denis P
J Glaucoma; 2008 Dec; 17(8):667-73. PubMed ID: 19092464
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension.
Katz LJ; Simmons ST; Craven ER
Curr Med Res Opin; 2007 Dec; 23(12):2971-83. PubMed ID: 17949534
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
[TBL] [Abstract][Full Text] [Related]
9. Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study.
Iskedjian M; Walker JH; Desjardins O; Robin AL; Covert DW; Bergamini MV; Einarson TR
Curr Med Res Opin; 2009 Aug; 25(8):1879-88. PubMed ID: 19530975
[TBL] [Abstract][Full Text] [Related]
10. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
Yildirim N; Sahin A; Gultekin S
J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
[TBL] [Abstract][Full Text] [Related]
11. Circadian IOP-lowering efficacy of travoprost 0.004% ophthalmic solution compared to latanoprost 0.005%.
García-Feijoo J; Martínez-de-la-Casa JM; Castillo A; Méndez C; Fernández-Vidal A; García-Sánchez J
Curr Med Res Opin; 2006 Sep; 22(9):1689-97. PubMed ID: 16968572
[TBL] [Abstract][Full Text] [Related]
12. Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials.
Varma R; Hwang LJ; Grunden JW; Bean GW
Am J Ophthalmol; 2008 Feb; 145(2):336-42. PubMed ID: 18222194
[TBL] [Abstract][Full Text] [Related]
13. A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.
Simmons ST; Bernstein P; Hollander DA
Am J Ophthalmol; 2008 Sep; 146(3):473-7. PubMed ID: 18561893
[TBL] [Abstract][Full Text] [Related]
14. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
Holló G; Kóthy P
Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin receptor agonists as antiglaucoma agents (a patent review 2013 - 2018).
Angeli A; Supuran CT
Expert Opin Ther Pat; 2019 Oct; 29(10):793-803. PubMed ID: 31462124
[No Abstract] [Full Text] [Related]
16. Tafluprost for glaucoma.
Papadia M; Bagnis A; Scotto R; Traverso CE
Expert Opin Pharmacother; 2011 Oct; 12(15):2393-401. PubMed ID: 21916788
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
Williams RD; Cohen JS; Gross RL; Liu CC; Safyan E; Batoosingh AL;
Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
[TBL] [Abstract][Full Text] [Related]
18. Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma.
Quaranta L; Pizzolante T; Riva I; Haidich AB; Konstas AG; Stewart WC
Br J Ophthalmol; 2008 Sep; 92(9):1227-31. PubMed ID: 18586898
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandins in the eye: Function, expression, and roles in glaucoma.
Doucette LP; Walter MA
Ophthalmic Genet; 2017; 38(2):108-116. PubMed ID: 27070211
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of a systematic switch from latanoprost to travoprost in patients with glaucoma.
Kumar RS; Istiantoro VW; Hoh ST; Ho CL; Oen FT; Aung T
J Glaucoma; 2007; 16(7):606-9. PubMed ID: 18091178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
